About: http://data.cimple.eu/news-article/4dd4727b3c8873a03ef5be99d981dd5a238dc6f0a006a6f05201ea23

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://data.cimple.eu/news-article/4dd4727b3c8873a03ef5be99d981dd5a238dc6f0a006a6f05201ea23 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

Attributes	Values
rdf:type	schema:NewsArticle
schema:articleBody	UK-based pharmaceutical company AstraZeneca insisted on Friday its coronavirus vaccine was safe, after some countries suspended its use in response to concerns about a potential link to blood clots. "An analysis of our safety data of more than 10 million records has shown no evidence of an increased risk of pulmonary embolism or deep vein thrombosis in any defined age group, gender, batch or in any particular country" from the jab, a company spokesperson said. "In fact, the observed number of these types of events are significantly lower in those vaccinated than would be expected among the general population." The AstraZeneca jab, developed with Oxford University, forms the mainstay of Britain's vaccination programme, and of many developing economies. It is relatively cheap, and easier to store than other jabs. But it has been dogged by controversy in Europe, with some governments initially refusing to certify its use for people aged over 65 despite scientific advice finding no reason for limits. This week Denmark, Norway and Iceland have paused its use as a precaution after isolated reports of recipients developing blood clots. Italy and Austria have also banned the use of shots from separate batches, while Bulgaria and Thailand said they would delay its rollout. However, the World Health Organization earlier Friday said there was no reason to stop using the Covid-19 vaccine, stressing there was no causal link between the jab and any clotting. A range of health authorities have also insisted it is safe, including the European Medicines Agency. British Prime Minister Boris Johnson's official spokesman told reporters on Thursday: "We've been clear that it's both safe and effective... and when people are asked to come forward and take it, they should do so in confidence." Britain began the world's first mass vaccination drive against the coronavirus in December, underpinned largely by the Oxford-AstraZeneca jab and another from Pfizer-BioNTech. jit/jj/har
schema:headline	AstraZeneca says 'no evidence' of higher blood clots risk from vaccine
schema:mentions	Embolism This Week (American TV program) Thrombosis Bulgaria European Medicines Agency Medication Iceland Austria Jab University of Oxford Denmark Prime Minister of the United Kingdom Norway World Health Organization Thailand Boris Johnson AstraZeneca Italy European Union Vaccine Severe acute respiratory syndrome coronavirus 2 Coronavirus disease 2019 Deep vein thrombosis
schema:author	http://data.cimple.eu/organization/1f0054d541e000623a2c1e561a247c073ef6328e8be9ffafda7b3fcd
schema:datePublished	2021-03-12 (xsd:date)
http://data.cimple...sPoliticalLeaning	other political leaning
http://data.cimple...logy#hasSentiment	positive sentiment
http://data.cimple...readability_score	82 (xsd:integer)
http://data.cimple...entionsConspiracy	antivax conspiracy theory

Faceted Search & Find service v1.16.115 as of Oct 09 2023

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 5 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software